The company integrates R&D, production and sales, and mainly produces and sells pipeline-type automatic enzyme immunoassay workstations and related supporting products. Enzyme immunoassay line is an in vitro diagnostic instrument, mainly used to detect the antigen and antibody content in blood specimens of animal body, and clinically it is mainly used for detecting Hepatitis A, Hepatitis B, Hepatitis C, AIDS, syphilis and other items, and the related testing items are up to thousands of kinds. At present, it is the most classical method used for immune testing in various medical institutions. It is mainly used in the laboratories of hospitals at all levels, blood stations, disease control centers, customs, commodity inspection and other institutions.
The registered trademark of ADDCARE is "ADDCARE More Safety, More Love", which is our slogan; to improve the efficiency of the test, to protect the safety of the test personnel and their families, and to provide reliable test results. results is our pursuit.
Since its inception, ADDCARE has insisted on confidence, diligence, pragmatism and efficiency as the entrepreneurial spirit; excellent product quality, safe use of performance, reasonable sales price, timely and professional after-sales service as the corporate philosophy; the pursuit of excellence, people-oriented, sincere service, dedication to society as the corporate purpose of serving the community.
Legal representative: Liu Jie
Establishment date: 2006-08-02
Registered capital: 52,631,578,950,000 yuan
Region: Shandong Province
Unified social credit code: 91370600791536775R
Business status: in business ( Business Status：Operating (Open) Enterprise
Industry：Manufacturing industry
Company Type：Limited Liability Company (Natural Person Investment or Holding)
English Name：Yantai Addcare Bio-Tech Limited Company
Size of Personnel：100-499 Personnel
Business Address：No. 7, Hanjiang Road, Development Zone, Yantai
Enterprise Address：Yantai Development Zone, No. 7 Hanjiang Road
Business Scope: production, sales: I, II, III medical devices, instrumentation, automation equipment; research and development of biological products; import and export of goods and technology; computer software development, sales; investment in their own funds (without the approval of the financial regulatory authorities, shall not be engaged in the absorption of deposits, financial guarantees, wealth management on behalf of the customer and other financial services); enterprise management information Consulting. (Projects subject to approval by law, approved by the relevant departments before carrying out business activities)